Survival by Histologic Type Corrected for Hysterectomy for Patients with Uterine Cancer 2000 to 2015 SEER Statistics

Histologic type	Number of patients	5-year relative survival % (95% CI)
Endometrioid:
Localized	77,163	97.5 (97.3-99.7)
Regional	17,623	79.0 (78.3-79.7)
Distant	3997	24.4 (22.9-25.9)
Unknown	2330	71.7 (69.5-73.8)
Nonendometrioid:*
Localized	8391	84.6 (83.6-85.6)
Regional	6909	50.8 (48.3-52.2)
Distant	3943	13.8 (12.6-15.2)
Unknown	408	40.0 (34.5-45.5)

SEER: Surveillance Epidemiology and End Results Program.

* Uterine serous and clear cell cancers.

Data from: Clarke MA, Devesa SS, Harvey SV, Wentzensen N. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers. J Clin Oncol 2019; 37:1895.

Graphic 139473 Version 1.0

خرید پکیج

Survival by Histologic Type Corrected for Hysterectomy for Patients with Uterine Cancer 2000 to 2015 SEER Statistics